- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | ROK's Q1 Earnings Coming Up: What's in the Offing for the Stock? | ||
| Do | Strategic Acquisitions to Support STERIS Stock Amid Macro Issues | ||
| Do | Is Prologis Stock a Smart Hold for Your Portfolio Now? | ||
| Do | Alcoa's Q4 Earnings Surpass Estimates, Revenues Increase Y/Y | ||
| Do | What's in the Cards for Chubb Limited This Earnings Season? | ||
| Do | SL Green Secures Lease Expansion at One Madison, Sees Strong Demand | ||
| Do | Onto Stock Surges 30% in a Month: Will the Uptrend Continue? | ||
| Do | Should You Buy, Hold or Sell Stride Stock Ahead of Q2 Earnings? | ||
| Do | Is JWN Stock a Buy, Hold or Sell Post Holiday Sales Results? | ||
| Do | Ford Plunges 27% in 6 Months: Buy, Sell or Hold the Stock? | ||
| Do | IBM Stock Before Q4 Earnings: A Smart Buy or Risky Investment? | ||
| Do | Strong Communications Sales Aid APH's Q4 Earnings: Is the Stock a Buy? | ||
| Do | RCI Hospitality Expands Portfolio With Flight Club Acquisition | ||
| Do | SAP and Qualtrics Team Up to Enhance Employee Experiences | ||
| Do | Keros Therapeutics Stock Plunges 81% in 3 Months: Here's Why | ||
| Do | Here's Why Range Resources Stock is an Attractive Investment Bet | ||
| Do | Interparfums Q4 Sales Up 10% Year Over Year, Key Brands Boost Growth | ||
| Do | NTLA Begins Dosing in Pivotal Study on Hereditary Angioedema Candidate | ||
| Do | McCormick Q4 Earnings & Sales Beat Estimates, Organic Sales Grow | ||
| Do | RLI's Q4 Earnings Miss on Higher Expenses, Premiums Rise Y/Y | ||
| Do | Is Tesla Stock a Buy Ahead of Q4 Earnings? A Look at Key Predictions | ||
| Do | Here's Why Zoom Stock is Still a Top Buy Despite 36% Rally in 6 Months | ||
| Do | Itron & Encycle Collaborate for Energy Management Innovation | ||
| Do | Cadence to Boost Embedded Security Portfolio With Secure-IC, Stock Up | ||
| Do | Brinker Skyrockets 290% in a Year: Is the Stock Still Worth Buying? |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
